Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome

go back to reference Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https://doi.org/10.1038/ncomms5006CrossRefPubMed Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https://​doi.​org/​10.​1038/​ncomms5006CrossRefPubMed

go back to reference Al-Okaili RN, Krejza J, Woo JH, Wolf RL, O’Rourke DM, Judy KD, Poptani H, Melhem ER (2007) Intraaxial brain masses: MR imaging-based diagnostic strategy–initial experience. Radiology 243:539–550. https://doi.org/10.1148/radiol.2432060493CrossRefPubMed Al-Okaili RN, Krejza J, Woo JH, Wolf RL, O’Rourke DM, Judy KD, Poptani H, Melhem ER (2007) Intraaxial brain masses: MR imaging-based diagnostic strategy–initial experience. Radiology 243:539–550. https://​doi.​org/​10.​1148/​radiol.​2432060493CrossRefPubMed

go back to reference Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA (2011) The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117:1602–1611. https://doi.org/10.1002/cncr.25746CrossRefPubMed Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA (2011) The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117:1602–1611. https://​doi.​org/​10.​1002/​cncr.​25746CrossRefPubMed

go back to reference Andersen C, Astrup J, Gyldensted C (1994) Quantitative MR analysis of glucocorticoid effects on peritumoral edema associated with intracranial meningiomas and metastases. J Comput Assist Tomogr 18:509–518. https://doi.org/10.1097/00004728-199407000-00001CrossRefPubMed Andersen C, Astrup J, Gyldensted C (1994) Quantitative MR analysis of glucocorticoid effects on peritumoral edema associated with intracranial meningiomas and metastases. J Comput Assist Tomogr 18:509–518. https://​doi.​org/​10.​1097/​00004728-199407000-00001CrossRefPubMed

go back to reference Berghoff AS, Liao YX, Karreman MA, Ilhan-Mutlu A, Gunkel K, Sprick MR, Eisen C, Kessler T, Osswald M, Wunsche S, Feinauer M, Gril B, Marme F, Michel LL, Bago-Horvath Z, Sahm F, Becker N, Breckwoldt MO, Solecki G, Gommel M, Huang LL, Rubmann P, Thome CM, Ratliff M, Trumpp A, Steeg PS, Preusser M, Wick W, Winkler F (2021) Identification and characterization of cancer cells that initiate metastases to the brain and other organs. Mol Cancer Res 19:688–701. https://doi.org/10.1158/1541-7786.Mcr-20-0863CrossRefPubMed Berghoff AS, Liao YX, Karreman MA, Ilhan-Mutlu A, Gunkel K, Sprick MR, Eisen C, Kessler T, Osswald M, Wunsche S, Feinauer M, Gril B, Marme F, Michel LL, Bago-Horvath Z, Sahm F, Becker N, Breckwoldt MO, Solecki G, Gommel M, Huang LL, Rubmann P, Thome CM, Ratliff M, Trumpp A, Steeg PS, Preusser M, Wick W, Winkler F (2021) Identification and characterization of cancer cells that initiate metastases to the brain and other organs. Mol Cancer Res 19:688–701. https://​doi.​org/​10.​1158/​1541-7786.​Mcr-20-0863CrossRefPubMed

go back to reference Berman AT, Thukral AD, Hwang WT, Solin LJ, Vapiwala N (2013) Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment. Clin Breast Cancer 13:88–94. https://doi.org/10.1016/j.clbc.2012.11.001CrossRefPubMed Berman AT, Thukral AD, Hwang WT, Solin LJ, Vapiwala N (2013) Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment. Clin Breast Cancer 13:88–94. https://​doi.​org/​10.​1016/​j.​clbc.​2012.​11.​001CrossRefPubMed

go back to reference Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, Mak RH, Tamimi RM, Tempany CM, Swanton C, Hoffmann U, Schwartz LH, Gillies RJ, Huang RY, Aerts H (2019) Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin 69:127–157. https://doi.org/10.3322/caac.21552CrossRefPubMedPubMedCentral Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, Mak RH, Tamimi RM, Tempany CM, Swanton C, Hoffmann U, Schwartz LH, Gillies RJ, Huang RY, Aerts H (2019) Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin 69:127–157. https://​doi.​org/​10.​3322/​caac.​21552CrossRefPubMedPubMedCentral

go back to reference Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, Plecha D, Madabhushi A (2017) Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res 19:57. https://doi.org/10.1186/s13058-017-0846-1CrossRefPubMedPubMedCentral Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, Plecha D, Madabhushi A (2017) Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res 19:57. https://​doi.​org/​10.​1186/​s13058-017-0846-1CrossRefPubMedPubMedCentral

go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://​doi.​org/​10.​3322/​caac.​21492CrossRefPubMed

go back to reference Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, Wen PY, Dunn IF, Bi WL, Weiss SE, Haas-Kogan DA, Alexander BM, Aizer AA (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 19:1511–1521. https://doi.org/10.1093/neuonc/nox077CrossRefPubMedPubMedCentral Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, Wen PY, Dunn IF, Bi WL, Weiss SE, Haas-Kogan DA, Alexander BM, Aizer AA (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 19:1511–1521. https://​doi.​org/​10.​1093/​neuonc/​nox077CrossRefPubMedPubMedCentral

go back to reference Castaneda CA, Flores R, Rojas KY, Castillo M, Dolores-Cerna K, Flores C, Belmar-Lopez C, Milla E, Gomez H (2015) Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer. CNS Oncol 4:137–145. https://doi.org/10.2217/cns.15.5CrossRefPubMedPubMedCentral Castaneda CA, Flores R, Rojas KY, Castillo M, Dolores-Cerna K, Flores C, Belmar-Lopez C, Milla E, Gomez H (2015) Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer. CNS Oncol 4:137–145. https://​doi.​org/​10.​2217/​cns.​15.​5CrossRefPubMedPubMedCentral

go back to reference Chen BT, Jin T, Ye N, Mambetsariev I, Daniel E, Wang T, Wong CW, Rockne RC, Colen R, Holodny AI, Sampath S, Salgia R (2020) Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases. Magn Reson Imaging 69:49–56. https://doi.org/10.1016/j.mri.2020.03.002CrossRefPubMedPubMedCentral Chen BT, Jin T, Ye N, Mambetsariev I, Daniel E, Wang T, Wong CW, Rockne RC, Colen R, Holodny AI, Sampath S, Salgia R (2020) Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases. Magn Reson Imaging 69:49–56. https://​doi.​org/​10.​1016/​j.​mri.​2020.​03.​002CrossRefPubMedPubMedCentral

go back to reference Chen BT, Jin T, Ye N, Mambetsariev I, Wang T, Wong CW, Chen Z, Rockne RC, Colen RR, Holodny AI, Sampath S, Salgia R (2021) Predicting survival duration with MRI radiomics of brain metastases from non-small cell lung cancer. Front Oncol 11:621088. https://doi.org/10.3389/fonc.2021.621088CrossRefPubMedPubMedCentral Chen BT, Jin T, Ye N, Mambetsariev I, Wang T, Wong CW, Chen Z, Rockne RC, Colen RR, Holodny AI, Sampath S, Salgia R (2021) Predicting survival duration with MRI radiomics of brain metastases from non-small cell lung cancer. Front Oncol 11:621088. https://​doi.​org/​10.​3389/​fonc.​2021.​621088CrossRefPubMedPubMedCentral

go back to reference Demaerel R, van Loon J, Van Calenbergh F (2019) Outcome after surgery in supratentorial and infratentorial solitary brain metastasis. Acta Neurochir (Wien) 161:1047–1053. https://doi.org/10.1007/s00701-019-03865-wCrossRef Demaerel R, van Loon J, Van Calenbergh F (2019) Outcome after surgery in supratentorial and infratentorial solitary brain metastasis. Acta Neurochir (Wien) 161:1047–1053. https://​doi.​org/​10.​1007/​s00701-019-03865-wCrossRef

go back to reference Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, Aldape K, Cha S, Kuo MD (2008) Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A 105:5213–5218. https://doi.org/10.1073/pnas.0801279105CrossRefPubMedPubMedCentral Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, Aldape K, Cha S, Kuo MD (2008) Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A 105:5213–5218. https://​doi.​org/​10.​1073/​pnas.​0801279105CrossRefPubMedPubMedCentral

go back to reference Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rodriguez R, Barbosa-Morais NL, Ponder BAJ, Low YL, Bingham S, Haiman CA, Le Marchand L, Broeks A, Schmidt MK, Hopper J, Southey M, Beckmann MW, Fasching PA, Peto J, Johnson N, Bojesen SE, Nordestgaard B, Milne RL, Benitez J, Hamann U, Ko Y, Schmutzler RK, Burwinkel B, Schurmann P, Dork T, Heikkinen T, Nevanlinna H, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Chen XQ, Spurdle A, Change-Claude J, Flesch-Janys D, Couch FJ, Olson JE, Severi G, Baglietto L, Brresen-Dale AL, Kristensen V, Hunter DJ, Hankinson SE, Devilee P, Vreeswijk M, Lissowska J, Brinton L, Liu JJ, Hall P, Kang D, Yoo KY, Shen CY, Yu JC, Anton-Culver H, Ziogoas A, Sigurdson A, Struewing J, Easton DF, Garcia-Closas M, Humphreys MK, Morrison J, Pharoah PDP, Pooley KA, Chenevix-Trench G, SEARCH, EPIC, MEC, ABCS, ABCFS, BBCC, BBCS, CGPS, CNIO-BCS, GENICA, GC-HBOC, HABCS, HEBCS, KARBAC, KBCS, kConFab, Grp AM, MARIE, MCBCS, MCCS, NBCS, NHS, ORIGO, PBCS, SASBAC, SEBCS, TWBCS, UCIBCS, USRTS, BCAC (2009) Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18:1131–1139. https://doi.org/10.1093/hmg/ddn429CrossRefPubMedPubMedCentral Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rodriguez R, Barbosa-Morais NL, Ponder BAJ, Low YL, Bingham S, Haiman CA, Le Marchand L, Broeks A, Schmidt MK, Hopper J, Southey M, Beckmann MW, Fasching PA, Peto J, Johnson N, Bojesen SE, Nordestgaard B, Milne RL, Benitez J, Hamann U, Ko Y, Schmutzler RK, Burwinkel B, Schurmann P, Dork T, Heikkinen T, Nevanlinna H, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Chen XQ, Spurdle A, Change-Claude J, Flesch-Janys D, Couch FJ, Olson JE, Severi G, Baglietto L, Brresen-Dale AL, Kristensen V, Hunter DJ, Hankinson SE, Devilee P, Vreeswijk M, Lissowska J, Brinton L, Liu JJ, Hall P, Kang D, Yoo KY, Shen CY, Yu JC, Anton-Culver H, Ziogoas A, Sigurdson A, Struewing J, Easton DF, Garcia-Closas M, Humphreys MK, Morrison J, Pharoah PDP, Pooley KA, Chenevix-Trench G, SEARCH, EPIC, MEC, ABCS, ABCFS, BBCC, BBCS, CGPS, CNIO-BCS, GENICA, GC-HBOC, HABCS, HEBCS, KARBAC, KBCS, kConFab, Grp AM, MARIE, MCBCS, MCCS, NBCS, NHS, ORIGO, PBCS, SASBAC, SEBCS, TWBCS, UCIBCS, USRTS, BCAC (2009) Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18:1131–1139. https://​doi.​org/​10.​1093/​hmg/​ddn429CrossRefPubMedPubMedCentral

go back to reference Fabregat-Franco C, Stradella A, Navarro V, Linares J, Galdeano M, Recalde S, Velasco R, Simo M, Fernadez A, Venthecourt AC, Falo C, Vazquez S, Bergamino M, Villanueva R, Pernas S, Gil-Gil MJ (2021) Validation and comparison of breast graded prognostic assessment scores in patients with breast cancer and brain metastases. Clin Transl Oncol. https://doi.org/10.1007/s12094-021-02577-xCrossRefPubMed Fabregat-Franco C, Stradella A, Navarro V, Linares J, Galdeano M, Recalde S, Velasco R, Simo M, Fernadez A, Venthecourt AC, Falo C, Vazquez S, Bergamino M, Villanueva R, Pernas S, Gil-Gil MJ (2021) Validation and comparison of breast graded prognostic assessment scores in patients with breast cancer and brain metastases. Clin Transl Oncol. https://​doi.​org/​10.​1007/​s12094-021-02577-xCrossRefPubMed

go back to reference Franchino F, Ruda R, Soffietti R (2018) Mechanisms and therapy for cancer metastasis to the brain. Front Oncol 8:161. https://doi.org/10.3389/fonc.2018.00161CrossRefPubMedPubMedCentral Franchino F, Ruda R, Soffietti R (2018) Mechanisms and therapy for cancer metastasis to the brain. Front Oncol 8:161. https://​doi.​org/​10.​3389/​fonc.​2018.​00161CrossRefPubMedPubMedCentral

go back to reference Huang CY, Lee CC, Yang HC, Lin CJ, Wu HM, Chung WY, Shiau CY, Guo WY, Pan DH, Peng SJ (2020) Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery. J Neurooncol 146:439–449. https://doi.org/10.1007/s11060-019-03343-4CrossRefPubMed Huang CY, Lee CC, Yang HC, Lin CJ, Wu HM, Chung WY, Shiau CY, Guo WY, Pan DH, Peng SJ (2020) Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery. J Neurooncol 146:439–449. https://​doi.​org/​10.​1007/​s11060-019-03343-4CrossRefPubMed

go back to reference Hung MH, Liu CY, Shiau CY, Hsu CY, Tsai YF, Wang YL, Tai LC, King KL, Chao TC, Chiu JH, Su CH, Lo SS, Tzeng CH, Shyr YM, Tseng LM (2014) Effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients. PLoS ONE 9:e89389. https://doi.org/10.1371/journal.pone.0089389CrossRefPubMedPubMedCentral Hung MH, Liu CY, Shiau CY, Hsu CY, Tsai YF, Wang YL, Tai LC, King KL, Chao TC, Chiu JH, Su CH, Lo SS, Tzeng CH, Shyr YM, Tseng LM (2014) Effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients. PLoS ONE 9:e89389. https://​doi.​org/​10.​1371/​journal.​pone.​0089389CrossRefPubMedPubMedCentral

go back to reference Jackson A, O’Connor JP, Parker GJ, Jayson GC (2007) Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 13:3449–3459. https://doi.org/10.1158/1078-0432.CCR-07-0238CrossRefPubMed Jackson A, O’Connor JP, Parker GJ, Jayson GC (2007) Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 13:3449–3459. https://​doi.​org/​10.​1158/​1078-0432.​CCR-07-0238CrossRefPubMed

go back to reference Jacobs AH, Kracht LW, Gossmann A, Ruger MA, Thomas AV, Thiel A, Herholz K (2005) Imaging in neurooncology. NeuroRx 2:333–347. https://doi.org/10.1602/neurorx.2.2.333CrossRefPubMedPubMedCentral Jacobs AH, Kracht LW, Gossmann A, Ruger MA, Thomas AV, Thiel A, Herholz K (2005) Imaging in neurooncology. NeuroRx 2:333–347. https://​doi.​org/​10.​1602/​neurorx.​2.​2.​333CrossRefPubMedPubMedCentral

go back to reference Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271–3277. https://doi.org/10.1200/JCO.2009.25.9820CrossRefPubMed Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271–3277. https://​doi.​org/​10.​1200/​JCO.​2009.​25.​9820CrossRefPubMed

go back to reference Kim JH, Ko ES, Lim Y, Lee KS, Han BK, Ko EY, Hahn SY, Nam SJ (2017) Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes. Radiology 282:665–675. https://doi.org/10.1148/radiol.2016160261CrossRefPubMed Kim JH, Ko ES, Lim Y, Lee KS, Han BK, Ko EY, Hahn SY, Nam SJ (2017) Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes. Radiology 282:665–675. https://​doi.​org/​10.​1148/​radiol.​2016160261CrossRefPubMed

go back to reference Kirsch DG, Ledezma CJ, Mathews CS, Bhan AK, Ancukiewicz M, Hochberg FH, Loeffler JS (2005) Survival after brain metastases from breast cancer in the trastuzumab era. J Clin Oncol 23:2114–2116; author reply 2116–2117. https://doi.org/10.1200/JCO.2005.05.249 Kirsch DG, Ledezma CJ, Mathews CS, Bhan AK, Ancukiewicz M, Hochberg FH, Loeffler JS (2005) Survival after brain metastases from breast cancer in the trastuzumab era. J Clin Oncol 23:2114–2116; author reply 2116–2117. https://​doi.​org/​10.​1200/​JCO.​2005.​05.​249

go back to reference Kniep HC, Madesta F, Schneider T, Hanning U, Schonfeld MH, Schon G, Fiehler J, Gauer T, Werner R, Gellissen S (2019) Radiomics of brain MRI: utility in prediction of metastatic tumor type. Radiology 290:479–487. https://doi.org/10.1148/radiol.2018180946CrossRefPubMed Kniep HC, Madesta F, Schneider T, Hanning U, Schonfeld MH, Schon G, Fiehler J, Gauer T, Werner R, Gellissen S (2019) Radiomics of brain MRI: utility in prediction of metastatic tumor type. Radiology 290:479–487. https://​doi.​org/​10.​1148/​radiol.​2018180946CrossRefPubMed

go back to reference Kresovich JK, O’Brien KM, Xu Z, Weinberg CR, Sandler DP, Taylor JA (2020) Prediagnostic immune cell profiles and breast cancer. JAMA Netw Open 3:e1919536. https://doi.org/10.1001/jamanetworkopen.2019.19536CrossRefPubMedPubMedCentral Kresovich JK, O’Brien KM, Xu Z, Weinberg CR, Sandler DP, Taylor JA (2020) Prediagnostic immune cell profiles and breast cancer. JAMA Netw Open 3:e1919536. https://​doi.​org/​10.​1001/​jamanetworkopen.​2019.​19536CrossRefPubMedPubMedCentral

go back to reference Laakmann E, Witzel I, Scriba V, Grzyska U, Zu Eulenburg C, Burchardi N, Hesse T, Wurschmidt F, Fehm T, Mobus V, von Minckwitz G, Loibl S, Park-Simon TW, Mueller V (2016) Radiological patterns of brain metastases in breast cancer patients: a subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry. Int J Mol Sci 17. https://doi.org/10.3390/ijms17101615 Laakmann E, Witzel I, Scriba V, Grzyska U, Zu Eulenburg C, Burchardi N, Hesse T, Wurschmidt F, Fehm T, Mobus V, von Minckwitz G, Loibl S, Park-Simon TW, Mueller V (2016) Radiological patterns of brain metastases in breast cancer patients: a subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry. Int J Mol Sci 17. https://​doi.​org/​10.​3390/​ijms17101615

go back to reference Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK (2008) Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat 111:523–530. https://doi.org/10.1007/s10549-007-9806-2CrossRefPubMed Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK (2008) Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat 111:523–530. https://​doi.​org/​10.​1007/​s10549-007-9806-2CrossRefPubMed

go back to reference Lekanidi K, Evans AL, Shah J, Jaspan T, Baker L, Evans AJ (2013) Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients. Clin Radiol 68:1070–1073. https://doi.org/10.1016/j.crad.2013.05.091CrossRefPubMed Lekanidi K, Evans AL, Shah J, Jaspan T, Baker L, Evans AJ (2013) Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients. Clin Radiol 68:1070–1073. https://​doi.​org/​10.​1016/​j.​crad.​2013.​05.​091CrossRefPubMed

go back to reference Lentzsch S, Reichardt P, Weber F, Budach V, Dorken B (1999) Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer 35:580–585. https://doi.org/10.1016/s0959-8049(98)00421-3CrossRefPubMed Lentzsch S, Reichardt P, Weber F, Budach V, Dorken B (1999) Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer 35:580–585. https://​doi.​org/​10.​1016/​s0959-8049(98)00421-3CrossRefPubMed

go back to reference Leone JP, Lee AV, Brufsky AM (2015) Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy. Cancer Med 4:989–994. https://doi.org/10.1002/cam4.439CrossRefPubMedPubMedCentral Leone JP, Lee AV, Brufsky AM (2015) Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy. Cancer Med 4:989–994. https://​doi.​org/​10.​1002/​cam4.​439CrossRefPubMedPubMedCentral

go back to reference Leone JP, Leone J, Zwenger AO, Iturbe J, Leone BA, Vallejo CT (2017) Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis. Eur J Cancer 74:17–25. https://doi.org/10.1016/j.ejca.2016.12.015CrossRefPubMed Leone JP, Leone J, Zwenger AO, Iturbe J, Leone BA, Vallejo CT (2017) Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis. Eur J Cancer 74:17–25. https://​doi.​org/​10.​1016/​j.​ejca.​2016.​12.​015CrossRefPubMed

go back to reference Li X, Huang R, Ma L, Liu S, Zong X (2019) Locoregional surgical treatment improves the prognosis in primary metastatic breast cancer patients with a single distant metastasis except for brain metastasis. Breast 45:104–112. https://doi.org/10.1016/j.breast.2019.03.006CrossRefPubMed Li X, Huang R, Ma L, Liu S, Zong X (2019) Locoregional surgical treatment improves the prognosis in primary metastatic breast cancer patients with a single distant metastasis except for brain metastasis. Breast 45:104–112. https://​doi.​org/​10.​1016/​j.​breast.​2019.​03.​006CrossRefPubMed

go back to reference Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP (2008) Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer 113:2638–2645. https://doi.org/10.1002/cncr.23930CrossRefPubMed Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP (2008) Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer 113:2638–2645. https://​doi.​org/​10.​1002/​cncr.​23930CrossRefPubMed

go back to reference Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY, Response Assessment in Neuro-Oncology g (2015) Response assessment criteria for brain metastases proposal from the RANO group. Lancet Oncol 16:e270-278. https://doi.org/10.1016/S1470-2045(15)70057-4CrossRefPubMed Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY, Response Assessment in Neuro-Oncology g (2015) Response assessment criteria for brain metastases proposal from the RANO group. Lancet Oncol 16:e270-278. https://​doi.​org/​10.​1016/​S1470-2045(15)70057-4CrossRefPubMed

go back to reference Long JP, Li XN, Zhang F (2016) Targeting metabolism in breast cancer: how far we can go? World J Clin Oncol 7:122–130. https://doi.org/10.5306/wjco.v7.i1.122CrossRefPubMedPubMedCentral Long JP, Li XN, Zhang F (2016) Targeting metabolism in breast cancer: how far we can go? World J Clin Oncol 7:122–130. https://​doi.​org/​10.​5306/​wjco.​v7.​i1.​122CrossRefPubMedPubMedCentral

go back to reference Matsuo S, Watanabe J, Mitsuya K, Hayashi N, Nakasu Y, Hayashi M (2017) Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up. Breast Cancer Res Treat 162:169–179. https://doi.org/10.1007/s10549-017-4107-xCrossRefPubMed Matsuo S, Watanabe J, Mitsuya K, Hayashi N, Nakasu Y, Hayashi M (2017) Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up. Breast Cancer Res Treat 162:169–179. https://​doi.​org/​10.​1007/​s10549-017-4107-xCrossRefPubMed

go back to reference Mehrabian H, Detsky J, Soliman H, Sahgal A, Stanisz GJ (2019) Advanced magnetic resonance imaging techniques in management of brain metastases. Front Oncol 9:440. https://doi.org/10.3389/fonc.2019.00440CrossRefPubMedPubMedCentral Mehrabian H, Detsky J, Soliman H, Sahgal A, Stanisz GJ (2019) Advanced magnetic resonance imaging techniques in management of brain metastases. Front Oncol 9:440. https://​doi.​org/​10.​3389/​fonc.​2019.​00440CrossRefPubMedPubMedCentral

go back to reference Nam BH, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH, Ro J (2008) Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res 10:R20. https://doi.org/10.1186/bcr1870CrossRefPubMedPubMedCentral Nam BH, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH, Ro J (2008) Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res 10:R20. https://​doi.​org/​10.​1186/​bcr1870CrossRefPubMedPubMedCentral

go back to reference Niwinska A, Rudnicka H, Murawska M (2013) Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival. Med Oncol 30:408. https://doi.org/10.1007/s12032-012-0408-4CrossRefPubMedPubMedCentral Niwinska A, Rudnicka H, Murawska M (2013) Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival. Med Oncol 30:408. https://​doi.​org/​10.​1007/​s12032-012-0408-4CrossRefPubMedPubMedCentral

go back to reference Ogawa K, Yoshii Y, Nishimaki T, Tamaki N, Miyaguni T, Tsuchida Y, Kamada Y, Toita T, Kakinohana Y, Tamaki W, Iraha S, Adachi G, Hyodo A, Murayama S (2008) Treatment and prognosis of brain metastases from breast cancer. J Neurooncol 86:231–238. https://doi.org/10.1007/s11060-007-9469-1CrossRefPubMed Ogawa K, Yoshii Y, Nishimaki T, Tamaki N, Miyaguni T, Tsuchida Y, Kamada Y, Toita T, Kakinohana Y, Tamaki W, Iraha S, Adachi G, Hyodo A, Murayama S (2008) Treatment and prognosis of brain metastases from breast cancer. J Neurooncol 86:231–238. https://​doi.​org/​10.​1007/​s11060-007-9469-1CrossRefPubMed

go back to reference Ou D, Cao L, Xu C, Kirova Y, Chen JY (2019) Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast-GPA 0–2.0. Breast J 25:1134–1142. https://doi.org/10.1111/tbj.13426CrossRefPubMed Ou D, Cao L, Xu C, Kirova Y, Chen JY (2019) Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast-GPA 0–2.0. Breast J 25:1134–1142. https://​doi.​org/​10.​1111/​tbj.​13426CrossRefPubMed

go back to reference Park B, Lee HS, Lee JW, Park S (2019) Association of white blood cell count with breast cancer burden varies according to menopausal status, body mass index, and hormone receptor status: a case-control study. Sci Rep 9:5762. https://doi.org/10.1038/s41598-019-42234-6CrossRefPubMedPubMedCentral Park B, Lee HS, Lee JW, Park S (2019) Association of white blood cell count with breast cancer burden varies according to menopausal status, body mass index, and hormone receptor status: a case-control study. Sci Rep 9:5762. https://​doi.​org/​10.​1038/​s41598-019-42234-6CrossRefPubMedPubMedCentral

go back to reference Park H, Lim Y, Ko ES, Cho HH, Lee JE, Han BK, Ko EY, Choi JS, Park KW (2018) Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer. Clin Cancer Res 24:4705–4714. https://doi.org/10.1158/1078-0432.CCR-17-3783CrossRefPubMed Park H, Lim Y, Ko ES, Cho HH, Lee JE, Han BK, Ko EY, Choi JS, Park KW (2018) Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer. Clin Cancer Res 24:4705–4714. https://​doi.​org/​10.​1158/​1078-0432.​CCR-17-3783CrossRefPubMed

go back to reference Park YH, Park MJ, Ji SH, Yi SY, Lim DH, Nam DH, Lee JI, Park W, Choi DH, Huh SJ, Ahn JS, Kang WK, Park K, Im YH (2009) Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. Br J Cancer 100:894–900. https://doi.org/10.1038/sj.bjc.6604941CrossRefPubMedPubMedCentral Park YH, Park MJ, Ji SH, Yi SY, Lim DH, Nam DH, Lee JI, Park W, Choi DH, Huh SJ, Ahn JS, Kang WK, Park K, Im YH (2009) Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. Br J Cancer 100:894–900. https://​doi.​org/​10.​1038/​sj.​bjc.​6604941CrossRefPubMedPubMedCentral

go back to reference Patel DA, Xi J, Luo J, Hassan B, Thomas S, Ma CX, Campian JL (2019) Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer. Breast Cancer Res Treat 174:443–452. https://doi.org/10.1007/s10549-018-05106-7CrossRefPubMed Patel DA, Xi J, Luo J, Hassan B, Thomas S, Ma CX, Campian JL (2019) Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer. Breast Cancer Res Treat 174:443–452. https://​doi.​org/​10.​1007/​s10549-018-05106-7CrossRefPubMed

go back to reference Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, Zhang C, Chen Z, Kandula S, Zhong J, Press RH, Olson JJ, Oyesiku NM, Wait SD, Curran WJ, Shu HK, Prabhu RS (2016) Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis. Neurosurgery 79:279–285. https://doi.org/10.1227/NEU.0000000000001096CrossRefPubMed Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, Zhang C, Chen Z, Kandula S, Zhong J, Press RH, Olson JJ, Oyesiku NM, Wait SD, Curran WJ, Shu HK, Prabhu RS (2016) Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis. Neurosurgery 79:279–285. https://​doi.​org/​10.​1227/​NEU.​0000000000001096​CrossRefPubMed

go back to reference Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD, Herceptin Adjuvant Trial Study T (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353:1659–1672. https://doi.org/10.1056/NEJMoa052306CrossRefPubMed Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD, Herceptin Adjuvant Trial Study T (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353:1659–1672. https://​doi.​org/​10.​1056/​NEJMoa052306CrossRefPubMed

go back to reference Pope WB (2018) Brain metastases: neuroimaging. Handb Clin Neurol 149:89–112. https://doi.org/10.1016/B978-0-12-811161-1.00007-4CrossRefPubMedPubMedCentral Pope WB (2018) Brain metastases: neuroimaging. Handb Clin Neurol 149:89–112. https://​doi.​org/​10.​1016/​B978-0-12-811161-1.​00007-4CrossRefPubMedPubMedCentral

go back to reference Press DJ, Miller ME, Liederbach E, Yao K, Huo D (2017) De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Clin Exp Metastasis 34:457–465. https://doi.org/10.1007/s10585-017-9871-9CrossRefPubMed Press DJ, Miller ME, Liederbach E, Yao K, Huo D (2017) De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Clin Exp Metastasis 34:457–465. https://​doi.​org/​10.​1007/​s10585-017-9871-9CrossRefPubMed

go back to reference Rasmussen IA Jr, Lindseth F, Rygh OM, Berntsen EM, Selbekk T, Xu J, Nagelhus Hernes TA, Harg E, Haberg A, Unsgaard G (2007) Functional neuronavigation combined with intra-operative 3D ultrasound: initial experiences during surgical resections close to eloquent brain areas and future directions in automatic brain shift compensation of preoperative data. Acta Neurochir (Wien) 149:365–378. https://doi.org/10.1007/s00701-006-1110-0CrossRef Rasmussen IA Jr, Lindseth F, Rygh OM, Berntsen EM, Selbekk T, Xu J, Nagelhus Hernes TA, Harg E, Haberg A, Unsgaard G (2007) Functional neuronavigation combined with intra-operative 3D ultrasound: initial experiences during surgical resections close to eloquent brain areas and future directions in automatic brain shift compensation of preoperative data. Acta Neurochir (Wien) 149:365–378. https://​doi.​org/​10.​1007/​s00701-006-1110-0CrossRef

go back to reference Rostami R, Mittal S, Rostami P, Tavassoli F, Jabbari B (2016) Brain metastasis in breast cancer: a comprehensive literature review. J Neurooncol 127:407–414. https://doi.org/10.1007/s11060-016-2075-3CrossRefPubMed Rostami R, Mittal S, Rostami P, Tavassoli F, Jabbari B (2016) Brain metastasis in breast cancer: a comprehensive literature review. J Neurooncol 127:407–414. https://​doi.​org/​10.​1007/​s11060-016-2075-3CrossRefPubMed

go back to reference Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Kalkanis SN (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:103–114. https://doi.org/10.1007/s11060-009-0057-4CrossRefPubMed Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Kalkanis SN (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:103–114. https://​doi.​org/​10.​1007/​s11060-009-0057-4CrossRefPubMed

go back to reference Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182. https://doi.org/10.1126/science.3798106CrossRefPubMed Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182. https://​doi.​org/​10.​1126/​science.​3798106CrossRefPubMed

go back to reference Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J, Breast Cancer International Research G (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365:1273–1283. https://doi.org/10.1056/NEJMoa0910383CrossRefPubMedPubMedCentral Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J, Breast Cancer International Research G (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365:1273–1283. https://​doi.​org/​10.​1056/​NEJMoa0910383CrossRefPubMedPubMedCentral

go back to reference Soffietti R, Abacioglu U, Baumert B, Combs SE, Kinhult S, Kros JM, Marosi C, Metellus P, Radbruch A, Villa Freixa SS, Brada M, Carapella CM, Preusser M, Le Rhun E, Ruda R, Tonn JC, Weber DC, Weller M (2017) Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol 19:162–174. https://doi.org/10.1093/neuonc/now241CrossRefPubMedPubMedCentral Soffietti R, Abacioglu U, Baumert B, Combs SE, Kinhult S, Kros JM, Marosi C, Metellus P, Radbruch A, Villa Freixa SS, Brada M, Carapella CM, Preusser M, Le Rhun E, Ruda R, Tonn JC, Weber DC, Weller M (2017) Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol 19:162–174. https://​doi.​org/​10.​1093/​neuonc/​now241CrossRefPubMedPubMedCentral

go back to reference Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, Heimans J, Hildebrand J, Hoskin P, Kalljo M, Krauseneck P, Marosi C, Siegal T, Vecht C (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13:674–681. https://doi.org/10.1111/j.1468-1331.2006.01506.xCrossRefPubMed Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, Heimans J, Hildebrand J, Hoskin P, Kalljo M, Krauseneck P, Marosi C, Siegal T, Vecht C (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13:674–681. https://​doi.​org/​10.​1111/​j.​1468-1331.​2006.​01506.​xCrossRefPubMed

go back to reference Spanberger T, Berghoff AS, Dinhof C, Ilhan-Mutlu A, Magerle M, Hutterer M, Pichler J, Wohrer A, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M (2013) Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases. Clin Exp Metastasis 30:357–368. https://doi.org/10.1007/s10585-012-9542-9CrossRefPubMed Spanberger T, Berghoff AS, Dinhof C, Ilhan-Mutlu A, Magerle M, Hutterer M, Pichler J, Wohrer A, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M (2013) Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases. Clin Exp Metastasis 30:357–368. https://​doi.​org/​10.​1007/​s10585-012-9542-9CrossRefPubMed

go back to reference Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2012) Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 82:2111–2117. https://doi.org/10.1016/j.ijrobp.2011.02.027CrossRefPubMed Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2012) Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 82:2111–2117. https://​doi.​org/​10.​1016/​j.​ijrobp.​2011.​02.​027CrossRefPubMed

go back to reference Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto W, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, Yu J, Chiang V, Nakano T, Aoyama H, Mehta MP (2020) Beyond an updated graded prognostic assessment (Breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. Int J Radiat Oncol Biol Phys 107:334–343. https://doi.org/10.1016/j.ijrobp.2020.01.051CrossRefPubMedPubMedCentral Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto W, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, Yu J, Chiang V, Nakano T, Aoyama H, Mehta MP (2020) Beyond an updated graded prognostic assessment (Breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. Int J Radiat Oncol Biol Phys 107:334–343. https://​doi.​org/​10.​1016/​j.​ijrobp.​2020.​01.​051CrossRefPubMedPubMedCentral

go back to reference Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto WA, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, An Y, Chiang V, Nakano T, Aoyama H, Mehta MP (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38:3773–3784. https://doi.org/10.1200/JCO.20.01255CrossRefPubMedPubMedCentral Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto WA, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, An Y, Chiang V, Nakano T, Aoyama H, Mehta MP (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38:3773–3784. https://​doi.​org/​10.​1200/​JCO.​20.​01255CrossRefPubMedPubMedCentral

go back to reference Subbiah IM, Lei X, Weinberg JS, Sulman EP, Chavez-MacGregor M, Tripathy D, Gupta R, Varma A, Chouhan J, Guevarra RP, Valero V, Gilbert MR, Gonzalez-Angulo AM (2015) Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases. J Clin Oncol 33:2239–2245. https://doi.org/10.1200/JCO.2014.58.8517CrossRefPubMedPubMedCentral Subbiah IM, Lei X, Weinberg JS, Sulman EP, Chavez-MacGregor M, Tripathy D, Gupta R, Varma A, Chouhan J, Guevarra RP, Valero V, Gilbert MR, Gonzalez-Angulo AM (2015) Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases. J Clin Oncol 33:2239–2245. https://​doi.​org/​10.​1200/​JCO.​2014.​58.​8517CrossRefPubMedPubMedCentral

go back to reference Susko M, Yu Y, Ma L, Nakamura J, Fogh S, Raleigh DR, Golden E, Theodosopoulos PV, McDermott MW, Sneed PK, Braunstein SE (2019) Preoperative dural contact and recurrence risk after surgical cavity stereotactic radiosurgery for brain metastases: new evidence in support of consensus guidelines. Adv Radiat Oncol 4:458–465. https://doi.org/10.1016/j.adro.2019.03.002CrossRefPubMedPubMedCentral Susko M, Yu Y, Ma L, Nakamura J, Fogh S, Raleigh DR, Golden E, Theodosopoulos PV, McDermott MW, Sneed PK, Braunstein SE (2019) Preoperative dural contact and recurrence risk after surgical cavity stereotactic radiosurgery for brain metastases: new evidence in support of consensus guidelines. Adv Radiat Oncol 4:458–465. https://​doi.​org/​10.​1016/​j.​adro.​2019.​03.​002CrossRefPubMedPubMedCentral

go back to reference Sze G, Milano E, Johnson C, Heier L (1990) Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11:785–791PubMedPubMedCentral Sze G, Milano E, Johnson C, Heier L (1990) Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11:785–791PubMedPubMedCentral

go back to reference Tai CH, Wu CC, Hwang ME, Saraf A, Grubb C, Jani A, Lapa ME, Andrews JIS, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJ (2018) Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases. CNS Oncol 7:25–34. https://doi.org/10.2217/cns-2017-0023CrossRefPubMedPubMedCentral Tai CH, Wu CC, Hwang ME, Saraf A, Grubb C, Jani A, Lapa ME, Andrews JIS, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJ (2018) Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases. CNS Oncol 7:25–34. https://​doi.​org/​10.​2217/​cns-2017-0023CrossRefPubMedPubMedCentral

go back to reference Thompson PA, Brewster AM, Kim-Anh D, Baladandayuthapani V, Broom BM, Edgerton ME, Hahn KM, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy ML (2011) Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS ONE 6:e23543. https://doi.org/10.1371/journal.pone.0023543CrossRefPubMedPubMedCentral Thompson PA, Brewster AM, Kim-Anh D, Baladandayuthapani V, Broom BM, Edgerton ME, Hahn KM, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy ML (2011) Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS ONE 6:e23543. https://​doi.​org/​10.​1371/​journal.​pone.​0023543CrossRefPubMedPubMedCentral

go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://​doi.​org/​10.​3322/​caac.​21262CrossRefPubMed

go back to reference Wang J, Wang S, Tang Y, Jing H, Sun G, Jin J, Liu Y, Song Y, Wang W, Fang H, Ren H, Yu Z, Li Y (2018) Comparison of treatment outcomes with breast-conserving surgery plus radiotherapy versus mastectomy for patients with stage I breast cancer: a propensity score-matched analysis. Clin Breast Cancer 18:e975–e984. https://doi.org/10.1016/j.clbc.2018.06.002CrossRefPubMed Wang J, Wang S, Tang Y, Jing H, Sun G, Jin J, Liu Y, Song Y, Wang W, Fang H, Ren H, Yu Z, Li Y (2018) Comparison of treatment outcomes with breast-conserving surgery plus radiotherapy versus mastectomy for patients with stage I breast cancer: a propensity score-matched analysis. Clin Breast Cancer 18:e975–e984. https://​doi.​org/​10.​1016/​j.​clbc.​2018.​06.​002CrossRefPubMed

go back to reference Wronski M, Arbit E, Burt M, Galicich JH (1995) Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 83:605–616. https://doi.org/10.3171/jns.1995.83.4.0605CrossRefPubMed Wronski M, Arbit E, Burt M, Galicich JH (1995) Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 83:605–616. https://​doi.​org/​10.​3171/​jns.​1995.​83.​4.​0605CrossRefPubMed

go back to reference Yamasaki F, Kolakshyapati M, Takano M, Yonezawa U, Nishibuchi I, Imano N, Taguchi A, Onishi S, Amatya VJ, Takeshima Y, Nagata Y, Kurisu K, Sugiyama K (2019) Effect of bevacizumab against cystic components of brain tumors. Cancer Med 8:6519–6527. https://doi.org/10.1002/cam4.2537CrossRefPubMedPubMedCentral Yamasaki F, Kolakshyapati M, Takano M, Yonezawa U, Nishibuchi I, Imano N, Taguchi A, Onishi S, Amatya VJ, Takeshima Y, Nagata Y, Kurisu K, Sugiyama K (2019) Effect of bevacizumab against cystic components of brain tumors. Cancer Med 8:6519–6527. https://​doi.​org/​10.​1002/​cam4.​2537CrossRefPubMedPubMedCentral

go back to reference Zafir-Lavie I, Sherbo S, Goltsman H, Badinter F, Yeini E, Ofek P, Miari R, Tal O, Liran A, Shatil T, Krispel S, Shapir N, Neil GA, Benhar I, Panet A, Satchi-Fainaro R (2018) Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases. J Control Release 291:80–89. https://doi.org/10.1016/j.jconrel.2018.10.017CrossRefPubMed Zafir-Lavie I, Sherbo S, Goltsman H, Badinter F, Yeini E, Ofek P, Miari R, Tal O, Liran A, Shatil T, Krispel S, Shapir N, Neil GA, Benhar I, Panet A, Satchi-Fainaro R (2018) Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases. J Control Release 291:80–89. https://​doi.​org/​10.​1016/​j.​jconrel.​2018.​10.​017CrossRefPubMed

go back to reference Zheng Y, Geng D, Yu T, Xia W, She D, Liu L, Yin B (2020) Prognostic value of pretreatment MRI texture features in breast cancer brain metastasis treated with Gamma Knife radiosurgery. Acta Radiol:284185120956296. https://doi.org/10.1177/0284185120956296 Zheng Y, Geng D, Yu T, Xia W, She D, Liu L, Yin B (2020) Prognostic value of pretreatment MRI texture features in breast cancer brain metastasis treated with Gamma Knife radiosurgery. Acta Radiol:284185120956296. https://​doi.​org/​10.​1177/​0284185120956296​